SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000921895-17-002050
Filing Date
2017-08-08
Accepted
2017-08-07 20:29:22
Documents
4

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d07422010_08072017.htm SC 13D 245799
2 SUBSCRIPTION AGREEMENT ex991to13d07422010_08072017.htm EX-99.1 88217
3 VOTING AND STANDSTILL AGREEMENT ex992to13d07422010_08072017.htm EX-99.2 39137
4 JOINT FILING AGREEMENT ex993to13d07422010_08072017.htm EX-99.3 16346
  Complete submission text file 0000921895-17-002050.txt   391183
Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 6282 Investment Advice

Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Subject) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86614 | Film No.: 171013070
SIC: 2834 Pharmaceutical Preparations